News

Public dispute escalates as Apple sues OpenAI and Musk renews criticism while defending SpaceX's AI infrastructure plans.

The lawsuit, which accuses OpenAI of stealing Apple’s hardware and trade secrets, marks a dramatic turn for two companies that were close partners.

The two billionaires exchanged barbs on X over Apple's allegations that OpenAI is stealing operational secrets related to Apple's proprietary hardware.

Navitas is facing intense scrutiny as Wolfspeed filed a patent infringement lawsuit against it. How should you play Navitas now?

Several Midtown blocks were shut down earlier this week after structural problems put the high-rise building at risk of partial collapse.

Chinese regulators have summoned JD.com over alleged false advertising during the recent 618 shopping festival. The scrutiny centers on how promotional offers and discounts were presented during one of China's key mid year sales events. Law firm Pomerantz LLP has launched a securities fraud investigation linked to this regulatory action on behalf of JD.com investors. JD.com, listed on the NasdaqGS under the ticker NasdaqGS:JD, now sits in the spotlight as regulators and investors assess the...

Intuitive Surgical (ISRG) is in focus after voluntarily recalling certain Da Vinci surgical system components tied to a potential E-brake pin issue. This development is prompting fresh attention on product risk and how it might factor into the stock. See our latest analysis for Intuitive Surgical. Against this backdrop, Intuitive Surgical’s short term share price momentum has softened, with the stock down 4.5% over the past week and 9.7% over the past 90 days. However, the 3 year total...

The lawsuit alleges that two former Apple employees now working at OpenAI stole confidential data including information about unreleased hardware products and technical specifications.

Uber Technologies (NYSE:UBER) has introduced new contract provisions that require plaintiffs to disclose third party litigation funding arrangements in lawsuits against the company. At the same time, rideshare drivers are organizing protests in response to rapid automation efforts and reports of AI driven pay cuts. These developments are reshaping Uber's legal posture and raising fresh questions about the future role of human drivers on the platform. Uber Technologies sits at the center of...

Sony’s move enraged thousands of gamers and brought on a lawsuit with the backdrop of rival Xbox’s restructuring amid video game industry challenges.

If you have ever caught yourself doom scrolling on Instagram or Facebook for hours on end and felt bad, don't; the technology is working exactly how it was intended to. Everything from the length and style of the Reels to the algorithms' encyclopedic knowledge of your likes and dislikes is designed ...

Johnson & Johnson expects U.S. physicians to perform the first procedures with the device this summer as it starts a phased commercial rollout.

Wolfspeed’s patent infringement lawsuit against Navitas Semiconductor (NVTS) has quickly become a key focus for investors, with allegations centered on gallium nitride and silicon carbide products that sit at the heart of both companies’ power chip offerings. See our latest analysis for Navitas Semiconductor. Recent trading in Navitas Semiconductor reflects this tension, with the share price at $13.36 after a 1-day share price return that declined 4.5% and a 30-day share price return that...

Wolfspeed has filed a patent infringement lawsuit against Navitas Semiconductor (NasdaqGM:NVTS), alleging misuse of multiple GaN and SiC power technologies. The case centers on technologies used in chips that support AI data centers, electric vehicles, and renewable energy applications. Navitas has publicly rejected the claims and highlighted its own patent portfolio and intent to contest the lawsuit. Navitas Semiconductor focuses on gallium nitride and silicon carbide power chips that aim...

Recent interest in Pfizer (PFE) has been driven by U.S. regulators approving IBRANCE as the first CDK4/6 inhibitor maintenance therapy for HR+, HER2+ metastatic breast cancer after induction treatment. This approval opens an additional use for this oncology drug. See our latest analysis for Pfizer. Despite the positive IBRANCE news and a long dividend track record, Pfizer’s recent share price performance has been weak. The stock is down over the past month and quarter, while the 1-year total...

Four US states are seeking $1.4 trillion in penalties from Meta Platforms over allegations that its platforms addict young users. The case targets core design and engagement features across Meta’s social apps and is set for trial in August. The penalty request is close to Meta’s current market value, raising questions about regulatory risk and future operating flexibility. Meta Platforms, NasdaqGS:META, faces this legal fight with its stock trading at around $615.58 and a mixed recent...

Navitas Semiconductor (NASDAQ:NVTS) shares fell 7% on Wednesday morning after Wolfspeed (NYSE:WOLF) filed a patent infringement lawsuit against the company in the U. S.

PARIS, July 8 (Reuters) - France's competition authority on Wednesday ordered Meta Platforms to resume talks with French media groups over payments for publishing content, after the publishers

Amgen (AMGN) has moved into focus after initiating voluntary nationwide recalls of certain Corlanor and Sensipar tablet lots due to foreign substances and CGMP deviations, prompting investors to reassess drug quality and compliance risks. See our latest analysis for Amgen. Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...

Market Domination Host Josh Lipton tracks several of the day's top trending stock tickers, including JPMorgan analysts raising their price target on Eli Lilly (LLY) stock, Vertex Pharmaceuticals' (VRTX) acquisition of Crinetics (CRNX), and the possible $1.4 trillion lawsuit that multiple states are now suing Meta Platforms (META) for.

Amgen has initiated several product recalls in the US for Sensipar (cinacalcet) and Corlanor (ivabradine). The recalls involve multiple lots, dosage strengths, and large product quantities distributed nationwide. Regulators cited current good manufacturing practice (CGMP) deviations and contamination concerns affecting certain products. The pattern of recurring recalls extends beyond a single isolated lot or event. For investors following Amgen, ticker NasdaqGS:AMGN, the scale and...

On June 1, Michael Saylor-led Strategy (Nasdaq: MSTR), formerly MicroStrategy, announced that it sold 32 Bitcoin (BTC) for roughly $2.5 million between May 26 and May 31. It was the leading Bitcoin treasury company's first sale since 2022 and sparked a lot of volatility in ...

The recalls cover Mustang wiper issues and Mustang Mach-E drivetrain parts.

(Bloomberg) -- China’s securities regulator said it was monitoring developments in a US lawsuit after Susquehanna International Group alleged insider traders made at least $100 million from well-timed options bets before Beijing’s recent crackdown on illegal cross-border trading. Most Read from BloombergGreece Offers Bounty to Catch Ravenous Fish Lured by Warming SeaMicrosoft’s Xbox to Cut 3,200 Jobs, Divest Five Studios in Major OverhaulTwo Millennium Trading Pods Made About $3.7 Billion Last M

Four US states seek $1.4 trillion from Meta over teen addiction claims. See why Meta stock barely moved on the news.

The Paramount Skydance deal faces more regulatory attention.

Pfizer's IBRANCE has received new FDA approval as the first CDK4/6 inhibitor maintenance therapy for HR+, HER2+ metastatic breast cancer after induction treatment. The approval covers use of IBRANCE in combination with trastuzumab and endocrine therapy for patients with this subtype of breast cancer. The decision is based on results from the Phase 3 PATINA trial. For investors watching Pfizer (NYSE:PFE), this approval adds a fresh clinical milestone to a stock that has faced pressure in...

Ford ranked No. 1 among mass-market brands in J.D. Power's initial quality study.

European Court of Justice upholds a €4.1b antitrust fine against Alphabet on its Android practices. Ruling is final and concludes a multi year legal dispute over Android market dominance in Europe. Decision increases regulatory pressure on Alphabet's core search and mobile ecosystems globally. For investors tracking Alphabet, ticker NasdaqGS:GOOGL, this ruling directly touches the foundations of its Android, search, and app distribution businesses. Alphabet runs one of the most widely used...

NuScale Power (NYSE:SMR) is facing a legal challenge over claims it misrepresented the project experience of commercialization partner ENTRA1 in investor communications. The dispute raises questions about disclosure practices and potential legal and reputational consequences for future NuScale projects. Separately, NuScale awarded Paragon an engineering contract to design the highly integrated protection system for its certified small modular reactor modules. NuScale is currently the only...